Global Parkinsons Disease Drug Market Growth 2022-2028

Global Parkinsons Disease Drug Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Parkinsons Disease Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Parkinsons Disease Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Parkinsons Disease Drug by Country/Region, 2017, 2022 & 2028
2.2 Parkinsons Disease Drug Segment by Type
2.2.1 Carbidopa/Levodopa
2.2.2 Dopamine Receptor Agonists
2.2.3 MAO-Inhibitors
2.3 Parkinsons Disease Drug Sales by Type
2.3.1 Global Parkinsons Disease Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Parkinsons Disease Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Parkinsons Disease Drug Sale Price by Type (2017-2022)
2.4 Parkinsons Disease Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Other
2.5 Parkinsons Disease Drug Sales by Application
2.5.1 Global Parkinsons Disease Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Parkinsons Disease Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Parkinsons Disease Drug Sale Price by Application (2017-2022)
3 Global Parkinsons Disease Drug by Company
3.1 Global Parkinsons Disease Drug Breakdown Data by Company
3.1.1 Global Parkinsons Disease Drug Annual Sales by Company (2020-2022)
3.1.2 Global Parkinsons Disease Drug Sales Market Share by Company (2020-2022)
3.2 Global Parkinsons Disease Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Parkinsons Disease Drug Revenue by Company (2020-2022)
3.2.2 Global Parkinsons Disease Drug Revenue Market Share by Company (2020-2022)
3.3 Global Parkinsons Disease Drug Sale Price by Company
3.4 Key Manufacturers Parkinsons Disease Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Parkinsons Disease Drug Product Location Distribution
3.4.2 Players Parkinsons Disease Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Parkinsons Disease Drug by Geographic Region
4.1 World Historic Parkinsons Disease Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Parkinsons Disease Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Parkinsons Disease Drug Annual Revenue by Geographic Region
4.2 World Historic Parkinsons Disease Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Parkinsons Disease Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Parkinsons Disease Drug Annual Revenue by Country/Region
4.3 Americas Parkinsons Disease Drug Sales Growth
4.4 APAC Parkinsons Disease Drug Sales Growth
4.5 Europe Parkinsons Disease Drug Sales Growth
4.6 Middle East & Africa Parkinsons Disease Drug Sales Growth
5 Americas
5.1 Americas Parkinsons Disease Drug Sales by Country
5.1.1 Americas Parkinsons Disease Drug Sales by Country (2017-2022)
5.1.2 Americas Parkinsons Disease Drug Revenue by Country (2017-2022)
5.2 Americas Parkinsons Disease Drug Sales by Type
5.3 Americas Parkinsons Disease Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinsons Disease Drug Sales by Region
6.1.1 APAC Parkinsons Disease Drug Sales by Region (2017-2022)
6.1.2 APAC Parkinsons Disease Drug Revenue by Region (2017-2022)
6.2 APAC Parkinsons Disease Drug Sales by Type
6.3 APAC Parkinsons Disease Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Parkinsons Disease Drug by Country
7.1.1 Europe Parkinsons Disease Drug Sales by Country (2017-2022)
7.1.2 Europe Parkinsons Disease Drug Revenue by Country (2017-2022)
7.2 Europe Parkinsons Disease Drug Sales by Type
7.3 Europe Parkinsons Disease Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Parkinsons Disease Drug by Country
8.1.1 Middle East & Africa Parkinsons Disease Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Parkinsons Disease Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Parkinsons Disease Drug Sales by Type
8.3 Middle East & Africa Parkinsons Disease Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Parkinsons Disease Drug
10.3 Manufacturing Process Analysis of Parkinsons Disease Drug
10.4 Industry Chain Structure of Parkinsons Disease Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Parkinsons Disease Drug Distributors
11.3 Parkinsons Disease Drug Customer
12 World Forecast Review for Parkinsons Disease Drug by Geographic Region
12.1 Global Parkinsons Disease Drug Market Size Forecast by Region
12.1.1 Global Parkinsons Disease Drug Forecast by Region (2023-2028)
12.1.2 Global Parkinsons Disease Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Parkinsons Disease Drug Forecast by Type
12.7 Global Parkinsons Disease Drug Forecast by Application
13 Key Players Analysis
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Parkinsons Disease Drug Product Offered
13.1.3 Teva Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Novartis AG
13.2.1 Novartis AG Company Information
13.2.2 Novartis AG Parkinsons Disease Drug Product Offered
13.2.3 Novartis AG Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis AG Main Business Overview
13.2.5 Novartis AG Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Parkinsons Disease Drug Product Offered
13.3.3 GSK Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 AbbVie
13.4.1 AbbVie Company Information
13.4.2 AbbVie Parkinsons Disease Drug Product Offered
13.4.3 AbbVie Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 AbbVie Main Business Overview
13.4.5 AbbVie Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Parkinsons Disease Drug Product Offered
13.5.3 Merck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim Parkinsons Disease Drug Product Offered
13.6.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
13.7 Impax Laboratories
13.7.1 Impax Laboratories Company Information
13.7.2 Impax Laboratories Parkinsons Disease Drug Product Offered
13.7.3 Impax Laboratories Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Impax Laboratories Main Business Overview
13.7.5 Impax Laboratories Latest Developments
13.8 Lundbeck
13.8.1 Lundbeck Company Information
13.8.2 Lundbeck Parkinsons Disease Drug Product Offered
13.8.3 Lundbeck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Lundbeck Main Business Overview
13.8.5 Lundbeck Latest Developments
13.9 Sun Pharma
13.9.1 Sun Pharma Company Information
13.9.2 Sun Pharma Parkinsons Disease Drug Product Offered
13.9.3 Sun Pharma Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sun Pharma Main Business Overview
13.9.5 Sun Pharma Latest Developments
13.10 Wockhardt
13.10.1 Wockhardt Company Information
13.10.2 Wockhardt Parkinsons Disease Drug Product Offered
13.10.3 Wockhardt Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Wockhardt Main Business Overview
13.10.5 Wockhardt Latest Developments
13.11 UCB
13.11.1 UCB Company Information
13.11.2 UCB Parkinsons Disease Drug Product Offered
13.11.3 UCB Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 UCB Main Business Overview
13.11.5 UCB Latest Developments
13.12 Bausch Health
13.12.1 Bausch Health Company Information
13.12.2 Bausch Health Parkinsons Disease Drug Product Offered
13.12.3 Bausch Health Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Bausch Health Main Business Overview
13.12.5 Bausch Health Latest Developments
13.13 Acadia
13.13.1 Acadia Company Information
13.13.2 Acadia Parkinsons Disease Drug Product Offered
13.13.3 Acadia Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Acadia Main Business Overview
13.13.5 Acadia Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Parkinsons Disease Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Parkinsons Disease Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Carbidopa/Levodopa
Table 4. Major Players of Dopamine Receptor Agonists
Table 5. Major Players of MAO-Inhibitors
Table 6. Global Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 7. Global Parkinsons Disease Drug Sales Market Share by Type (2017-2022)
Table 8. Global Parkinsons Disease Drug Revenue by Type (2017-2022) & ($ million)
Table 9. Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2022)
Table 10. Global Parkinsons Disease Drug Sale Price by Type (2017-2022) & (USD/Dose)
Table 11. Global Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 12. Global Parkinsons Disease Drug Sales Market Share by Application (2017-2022)
Table 13. Global Parkinsons Disease Drug Revenue by Application (2017-2022)
Table 14. Global Parkinsons Disease Drug Revenue Market Share by Application (2017-2022)
Table 15. Global Parkinsons Disease Drug Sale Price by Application (2017-2022) & (USD/Dose)
Table 16. Global Parkinsons Disease Drug Sales by Company (2020-2022) & (K Doses)
Table 17. Global Parkinsons Disease Drug Sales Market Share by Company (2020-2022)
Table 18. Global Parkinsons Disease Drug Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Parkinsons Disease Drug Revenue Market Share by Company (2020-2022)
Table 20. Global Parkinsons Disease Drug Sale Price by Company (2020-2022) & (USD/Dose)
Table 21. Key Manufacturers Parkinsons Disease Drug Producing Area Distribution and Sales Area
Table 22. Players Parkinsons Disease Drug Products Offered
Table 23. Parkinsons Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Parkinsons Disease Drug Sales by Geographic Region (2017-2022) & (K Doses)
Table 27. Global Parkinsons Disease Drug Sales Market Share Geographic Region (2017-2022)
Table 28. Global Parkinsons Disease Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Parkinsons Disease Drug Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Parkinsons Disease Drug Sales by Country/Region (2017-2022) & (K Doses)
Table 31. Global Parkinsons Disease Drug Sales Market Share by Country/Region (2017-2022)
Table 32. Global Parkinsons Disease Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Parkinsons Disease Drug Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 35. Americas Parkinsons Disease Drug Sales Market Share by Country (2017-2022)
Table 36. Americas Parkinsons Disease Drug Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Parkinsons Disease Drug Revenue Market Share by Country (2017-2022)
Table 38. Americas Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 39. Americas Parkinsons Disease Drug Sales Market Share by Type (2017-2022)
Table 40. Americas Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 41. Americas Parkinsons Disease Drug Sales Market Share by Application (2017-2022)
Table 42. APAC Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 43. APAC Parkinsons Disease Drug Sales Market Share by Region (2017-2022)
Table 44. APAC Parkinsons Disease Drug Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Parkinsons Disease Drug Revenue Market Share by Region (2017-2022)
Table 46. APAC Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 47. APAC Parkinsons Disease Drug Sales Market Share by Type (2017-2022)
Table 48. APAC Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 49. APAC Parkinsons Disease Drug Sales Market Share by Application (2017-2022)
Table 50. Europe Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 51. Europe Parkinsons Disease Drug Sales Market Share by Country (2017-2022)
Table 52. Europe Parkinsons Disease Drug Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Parkinsons Disease Drug Revenue Market Share by Country (2017-2022)
Table 54. Europe Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 55. Europe Parkinsons Disease Drug Sales Market Share by Type (2017-2022)
Table 56. Europe Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 57. Europe Parkinsons Disease Drug Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 59. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Parkinsons Disease Drug Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Parkinsons Disease Drug Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 63. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 65. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Parkinsons Disease Drug
Table 67. Key Market Challenges & Risks of Parkinsons Disease Drug
Table 68. Key Industry Trends of Parkinsons Disease Drug
Table 69. Parkinsons Disease Drug Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Parkinsons Disease Drug Distributors List
Table 72. Parkinsons Disease Drug Customer List
Table 73. Global Parkinsons Disease Drug Sales Forecast by Region (2023-2028) & (K Doses)
Table 74. Global Parkinsons Disease Drug Sales Market Forecast by Region
Table 75. Global Parkinsons Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Parkinsons Disease Drug Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Parkinsons Disease Drug Sales Forecast by Country (2023-2028) & (K Doses)
Table 78. Americas Parkinsons Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Parkinsons Disease Drug Sales Forecast by Region (2023-2028) & (K Doses)
Table 80. APAC Parkinsons Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Parkinsons Disease Drug Sales Forecast by Country (2023-2028) & (K Doses)
Table 82. Europe Parkinsons Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Parkinsons Disease Drug Sales Forecast by Country (2023-2028) & (K Doses)
Table 84. Middle East & Africa Parkinsons Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Parkinsons Disease Drug Sales Forecast by Type (2023-2028) & (K Doses)
Table 86. Global Parkinsons Disease Drug Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Parkinsons Disease Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Parkinsons Disease Drug Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Parkinsons Disease Drug Sales Forecast by Application (2023-2028) & (K Doses)
Table 90. Global Parkinsons Disease Drug Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Parkinsons Disease Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Parkinsons Disease Drug Revenue Market Share Forecast by Application (2023-2028)
Table 93. Teva Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Teva Parkinsons Disease Drug Product Offered
Table 95. Teva Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 96. Teva Main Business
Table 97. Teva Latest Developments
Table 98. Novartis AG Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis AG Parkinsons Disease Drug Product Offered
Table 100. Novartis AG Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 101. Novartis AG Main Business
Table 102. Novartis AG Latest Developments
Table 103. GSK Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. GSK Parkinsons Disease Drug Product Offered
Table 105. GSK Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 106. GSK Main Business
Table 107. GSK Latest Developments
Table 108. AbbVie Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. AbbVie Parkinsons Disease Drug Product Offered
Table 110. AbbVie Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 111. AbbVie Main Business
Table 112. AbbVie Latest Developments
Table 113. Merck Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Merck Parkinsons Disease Drug Product Offered
Table 115. Merck Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 116. Merck Main Business
Table 117. Merck Latest Developments
Table 118. Boehringer Ingelheim Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Boehringer Ingelheim Parkinsons Disease Drug Product Offered
Table 120. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 121. Boehringer Ingelheim Main Business
Table 122. Boehringer Ingelheim Latest Developments
Table 123. Impax Laboratories Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Impax Laboratories Parkinsons Disease Drug Product Offered
Table 125. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 126. Impax Laboratories Main Business
Table 127. Impax Laboratories Latest Developments
Table 128. Lundbeck Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Lundbeck Parkinsons Disease Drug Product Offered
Table 130. Lundbeck Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 131. Lundbeck Main Business
Table 132. Lundbeck Latest Developments
Table 133. Sun Pharma Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Sun Pharma Parkinsons Disease Drug Product Offered
Table 135. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 136. Sun Pharma Main Business
Table 137. Sun Pharma Latest Developments
Table 138. Wockhardt Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 139. Wockhardt Parkinsons Disease Drug Product Offered
Table 140. Wockhardt Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 141. Wockhardt Main Business
Table 142. Wockhardt Latest Developments
Table 143. UCB Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 144. UCB Parkinsons Disease Drug Product Offered
Table 145. UCB Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 146. UCB Main Business
Table 147. UCB Latest Developments
Table 148. Bausch Health Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 149. Bausch Health Parkinsons Disease Drug Product Offered
Table 150. Bausch Health Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 151. Bausch Health Main Business
Table 152. Bausch Health Latest Developments
Table 153. Acadia Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 154. Acadia Parkinsons Disease Drug Product Offered
Table 155. Acadia Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 156. Acadia Main Business
Table 157. Acadia Latest Developments
List of Figures
Figure 1. Picture of Parkinsons Disease Drug
Figure 2. Parkinsons Disease Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Parkinsons Disease Drug Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Parkinsons Disease Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Parkinsons Disease Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Carbidopa/Levodopa
Figure 10. Product Picture of Dopamine Receptor Agonists
Figure 11. Product Picture of MAO-Inhibitors
Figure 12. Global Parkinsons Disease Drug Sales Market Share by Type in 2021
Figure 13. Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2022)
Figure 14. Parkinsons Disease Drug Consumed in Hospital
Figure 15. Global Parkinsons Disease Drug Market: Hospital (2017-2022) & (K Doses)
Figure 16. Parkinsons Disease Drug Consumed in Clinics
Figure 17. Global Parkinsons Disease Drug Market: Clinics (2017-2022) & (K Doses)
Figure 18. Parkinsons Disease Drug Consumed in Other
Figure 19. Global Parkinsons Disease Drug Market: Other (2017-2022) & (K Doses)
Figure 20. Global Parkinsons Disease Drug Sales Market Share by Application (2017-2022)
Figure 21. Global Parkinsons Disease Drug Revenue Market Share by Application in 2021
Figure 22. Parkinsons Disease Drug Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Parkinsons Disease Drug Revenue Market Share by Company in 2021
Figure 24. Global Parkinsons Disease Drug Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Parkinsons Disease Drug Revenue Market Share by Geographic Region in 2021
Figure 26. Global Parkinsons Disease Drug Sales Market Share by Region (2017-2022)
Figure 27. Global Parkinsons Disease Drug Revenue Market Share by Country/Region in 2021
Figure 28. Americas Parkinsons Disease Drug Sales 2017-2022 (K Doses)
Figure 29. Americas Parkinsons Disease Drug Revenue 2017-2022 ($ Millions)
Figure 30. APAC Parkinsons Disease Drug Sales 2017-2022 (K Doses)
Figure 31. APAC Parkinsons Disease Drug Revenue 2017-2022 ($ Millions)
Figure 32. Europe Parkinsons Disease Drug Sales 2017-2022 (K Doses)
Figure 33. Europe Parkinsons Disease Drug Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Parkinsons Disease Drug Sales 2017-2022 (K Doses)
Figure 35. Middle East & Africa Parkinsons Disease Drug Revenue 2017-2022 ($ Millions)
Figure 36. Americas Parkinsons Disease Drug Sales Market Share by Country in 2021
Figure 37. Americas Parkinsons Disease Drug Revenue Market Share by Country in 2021
Figure 38. United States Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Parkinsons Disease Drug Sales Market Share by Region in 2021
Figure 43. APAC Parkinsons Disease Drug Revenue Market Share by Regions in 2021
Figure 44. China Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Parkinsons Disease Drug Sales Market Share by Country in 2021
Figure 51. Europe Parkinsons Disease Drug Revenue Market Share by Country in 2021
Figure 52. Germany Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Parkinsons Disease Drug Revenue Market Share by Country in 2021
Figure 59. Egypt Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Parkinsons Disease Drug in 2021
Figure 65. Manufacturing Process Analysis of Parkinsons Disease Drug
Figure 66. Industry Chain Structure of Parkinsons Disease Drug
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs